Development of a benchmarking framework for pharmaceutical capital projects

Construction Management and Economics

Volumn 26, Issue 2, 2008, Pages 177-195

  Hwang, Bon Gang ^a   Thomas, Stephen R ^a   Degezelle, Deborah ^a   Caldas, Carlos H ^b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Benchmarking; Pharmaceutical project; Project management; Project performance

Indexed keywords

BENCHMARKING; COMPETITION; DRUG PRODUCTS PLANTS; SUSTAINABLE DEVELOPMENT;

PROJECT DELIVERY SYSTEM; PROJECT PERFORMANCE;

PROJECT MANAGEMENT;

BENCHMARKING; CAPITAL; PHARMACEUTICAL INDUSTRY; PROJECT ASSESSMENT; PROJECT MANAGEMENT;

EID: 39749114852     PISSN: 01446193     EISSN: 1466433X     Source Type: Journal    
DOI: 10.1080/01446190701802398     Document Type: Article

References (24)

1. Aleem, H., Zhao, Y., Lord, S., McCarthy, T. and Sharratt, P. (2003) Pharmaceutical process validation: An overview. Proceedings of the Institution of Mechanical Engineers, 217
2. Bakens, W., Viries, O. and Courtney, P. (2005) International Review of Benchmarking in Construction, Research Report, PSIBouw, Amsterdam, The Netherlands
3. Bender, R. H. (1996) Benchmark costs for pharmaceutical facilities. Pharmaceutical Engineering, 16:6, pp. 28-32.
4. CDT (Corporación de Desarrollo Tecnológico) (2002) National Benchmarking System for the Construction Industry
5. CII (Construction Industry Institute) (2005) Pharmaceutical Benchmarking Summary Report
6. Cole, C. G. (1998) Pharma Production Facilities Design and Applications, Taylor & Francis Inc., Bristol, PA
7. Costa, D. B., Formoso, C. T. and Lima, H. M. R. (2004) Procedures for Performance Measurement for Benchmarking in the Construction Industry: SISIND-NET Project, UFRGS/PPGEC/NORIE, Porto Alegre, Brazil (in Portuguese)
8. Costa, D. B., Formoso, C. T., Kagioglou, M., Alarcon, L. F. and Caldas, C. H. (2006) Benchmarking initiatives in the construction industry: lessons learned and improvement opportunities. Journal of Management in Engineering, 22:4, pp. 158-167.
9. Dysert, L. (2001) Sharpen your capital cost estimation skills. Chemical Engineering, 108:11
10. Hanscomb (2000) The Hanscomb/Means Report: International Construction Cost Intelligence
11. Hwang, B. G. (2006) Development of a performance measurement system for pharmaceutical capital facilities projects.
12. ISPE (International Society of Pharmaceutical Engineers) (1996) Pharmaceutical Engineering Guide for Oral Solid Dosage Forms
13. ISPE (1997) Pharmaceutical Engineering Guide for Bulk Pharmaceutical Chemical Facilities
14. ISPE (2003) Pharmaceutical Engineering Guide for Biopharmaceuticals
15. Jörg, K. (1999) Putting benchmarking into pharmaceutical practice: new benchmarking models are not necessarily the way to superior performance. Pharma Marketing Journal, pp. 6-14.
16. Kennedy, T. (1998) Pharmaceutical Project Management, Marcel Dekker Inc., New York
17. Kolkebeck, K. (2005) Pharmaceutical building automation for manufacturing. HPAC Engineering, pp. 25-30.
18. Leichter, G. and Turstam, L. (2004) An alternative approach to the modular design and construction of large-scale bulk biopharmaceutical manufacturing facilities. Pharmaceutical Engineering, pp. 8-22.
19. Maleyeff, J. (2003) Benchmarking performance indices: Pitfalls and solutions. Benchmarking: An International Journal, 10:1, pp. 9-28.
20. McCormick, K. (2003) Manufacturing in the Global Pharmaceuticals Industry: Key Drivers, Company Strategies and Regulations, Urch Publishing Ltd, Rockville, MD
21. Osborne, P. D. (1996) Investment cost benchmarks for pharmaceutical facilities. Pharmaceutical Engineering, 16:6, pp. 36-43.
22. RS Means (1999) Means Building Construction Cost Data. Various Cost and Historical Indices
23. Wilkins, M. J. (2003) Learning from the other guy: Benchmarking and best practices. Control Engineering, pp. 33-39.
24. Wrigley, G. C. (2004) Facility Validation: Theory, Practice, and Tools, CRC Press LLC, Boca Rayton, FL